Clinical Trial Update: Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

View source ↗

Summary

This is an observational long-term follow-up study related to patients treated with gene-modified T-cell therapy for relapsed or refractory multiple myeloma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory Multiple Myeloma

Drugs mentioned

• Gene-modified T-cell therapy (CAR-T)

Snippet

Sponsor: CARsgen Therapeutics Co., Ltd. | Conditions: Relapsed or Refractory Multiple Myeloma | Status: NOT_YET_RECRUITING